PM&R
Volume 2, Issue 8 , Pages 698-702 , August 2010

Rehabilitation Outcomes of Stroke Patients Treated With Tissue Plasminogen Activator

  • Zeev Meiner, MD

      Affiliations

    • Departments of Physical Medicine and Rehabilitation and Neurology, POB 24035, Hadassah-Hebrew University Medical Center, Jerusalem, 91240 Israel
    • Corresponding Author InformationAddress correspondence to: Z.M.
    • ,
  • Anna Sajin, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Isabella Schwartz, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Jeanna Tsenter, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Ivelin Yovchev, MD

      Affiliations

    • Department of Physical Medicine and Rehabilitation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Roni Eichel, MD

      Affiliations

    • Department of Neurology, Hadassah-Hebrew University Medical Center Jerusalem, Israel
    • ,
  • Tamir Ben-Hur, MD, PhD

      Affiliations

    • Department of Neurology, Hadassah-Hebrew University Medical Center Jerusalem, Israel
    • ,
  • Ronen R. Leker, MD

      Affiliations

    • Department of Neurology, Hadassah-Hebrew University Medical Center Jerusalem, Israel

Received 26 March 2010 ,Accepted 18 May 2010.

References 

  1. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engl J Med. 1995;333:1581–1587
  2. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: Pooled analysis of atlantis, ecass, and ninds rt-pa stroke trials. Lancet. 2004;363:768–774
  3. Broderick JP, Lu M, Kothari R, et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the ninds tpa stroke trial. Stroke. 2000;31:2335–2341
  4. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: The ninds rt-pa stroke study. Neurology. 2000;55:1649–1655
  5. De Wit L, Putman K, Schuback B, et al. Motor and functional recovery after stroke: A comparison of 4 european rehabilitation centers. Stroke. 2007;38:2101–2107
  6. DeJong G, Horn SD, Conroy B, Nichols D, Healton EB. Opening the black box of post-stroke rehabilitation: Stroke rehabilitation patients, processes, and outcomes. Arch Phys Med Rehabil. 2005;86:S1–S7
  7. Dobkin BH. Clinical practice (Rehabilitation after stroke). N Engl J Med. 2005;352:1677–1684
  8. Falconer JA, Naughton BJ, Strasser DC, Sinacore JM. Stroke inpatient rehabilitation: A comparison across age groups. J Am Geriatr Soc. 1994;42:39–44
  9. Kalra L, Langhorne P. Facilitating recovery: Evidence for organized stroke care. J Rehabil Med. 2007;39:97–102
  10. Kelly PJ, Furie KL, Shafqat S, Rallis N, Chang Y, Stein J. Functional recovery following rehabilitation after hemorrhagic and ischemic stroke. Arch Phys Med Rehabil. 2003;84:968–972
  11. Kwakkel G, van Peppen R, Wagenaar RC, et al. Effects of augmented exercise therapy time after stroke: A meta-analysis. Stroke. 2004;35:2529–2539
  12. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 1989;20:864–870
  13. Rankin J. Cerebral vascular accidents in patients over the age of 60. Ii. Prognosis. Scott Med J. 1957;2:200–215
  14. Keith RA, Granger CV, Hamilton BB, Sherwin FF. The functional independence measure: A new tool for rehabilitation. In:  Eisenberg MG,  Grzesiak RC editor. Advances in Clinical Rehabilitation. New York: Springer Verlag; 1987;p. 6–18
  15. How do stroke units improve patient outcomes? (A collaborative systematic review of the randomized trials). Stroke unit trialists collaboration (Stroke). 1997;28:2139–2144
  16. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007;CD000197
  17. Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A very early rehabilitation trial for stroke (avert): Phase ii safety and feasibility. Stroke. 2008;39:390–396
  18. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment improves long-term quality of life: A randomized controlled trial. Stroke. 1998;29:895–899
  19. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment (10-year follow-up). Stroke. 1999;30:1524–1527
  20. Langhorne P, Legg L. Therapy for stroke patients living at home (Outpatient therapy trialists). Lancet. 1999;354:1730–1731
  21. Langhorne P, Wagenaar R, Partridge C. Physiotherapy after stroke: More is better?. Physiother Res Int. 1996;1:75–88
  22. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year (National institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study group). N Engl J Med. 1999;340:1781–1787
  23. Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology. 2005;65:1169–1174
  24. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke. 2004;35:486–490
  25. Rubiera M, Alvarez-Sabin J, Ribo M, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36:1452–1456
  26. Nudo RJ. Postinfarct cortical plasticity and behavioral recovery. Stroke. 2007;38:840–845
  27. Komitova M, Johansson BB, Eriksson PS. On neural plasticity, new neurons and the postischemic milieu: An integrated view on experimental rehabilitation. Exp Neurol. 2006;199:42–55
  28. Leker RR, Soldner F, Velasco I, Gavin DK, Androutsellis-Theotokis A, McKay RD. Long-lasting regeneration after ischemia in the cerebral cortex. Stroke. 2007;38:153–161
  29. Ohab JJ, Carmichael ST. Poststroke neurogenesis: Emerging principles of migration and localization of immature neurons. Neuroscientist. 2008;14:369–380
  30. Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res. 2008;5:236–245
  31. Hayashi T, Deguchi K, Nagotani S, et al. Cerebral ischemia and angiogenesis. Curr Neurovasc Res. 2006;3:119–129

 Supported by the Peritz and Chantal Sheinberg Cerebrovascular Research Fund and by the Sol Irwin Juni Trust Fund.

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

 This CME activity is designated for 1.0 AMA PRA Category 1 Credit™ and can be completed online at me.aapmr.org. Log on to www.me.aapmr.org, go to Lifelong Learning (CME) and select Journal-based CME from the drop down menu. This activity is FREE to AAPM&R members and $25 for non-members.

PII: S1934-1482(10)00448-X

doi: 10.1016/j.pmrj.2010.04.029

PM&R
Volume 2, Issue 8 , Pages 698-702 , August 2010

Article Tools